US Broker Ratings

Royalty Pharma plc (RPRX) Stock Analysis: Exploring Its 8.72% Upside and Strategic Biopharma Investments

Royalty Pharma plc (NASDAQ: RPRX) continues to capture investor interest as a unique entity in the healthcare sector, specifically within the biotechnology industry. Based in New York City and boasting..

Insmed Incorporated (INSM) Stock Analysis: Unveiling an 88.25% Potential Upside in Biotech Innovation

Investors keeping an eye on the healthcare sector, particularly biotechnology, may find Insmed Incorporated (NASDAQ: INSM) an intriguing opportunity. With a market capitalization of $23.03 billion, Insmed stands as a..

GSK plc (GSK) Stock Analysis: Attractive 12.23% Potential Upside Amid Strong Dividend Yield

Investors eyeing opportunities in the healthcare sector might find GSK plc (GSK) a compelling case, with its robust market presence and promising growth potential. Headquartered in London, GSK sits prominently..

Stryker Corporation (SYK) Stock Analysis: A Medical Device Leader with a 23% Upside Potential

Stryker Corporation (NYSE: SYK), a titan in the healthcare sector known for its innovative medical devices, is capturing investor attention with a noteworthy potential upside of 23.02%. As the company..

Bristol-Myers Squibb (BMY) Stock Analysis: Evaluating Its 5.89% Upside Potential

For individual investors eyeing opportunities in the healthcare sector, Bristol-Myers Squibb Company (NYSE: BMY) presents a compelling case with its robust market presence and promising potential upside. With a market..

Incyte Corporation (INCY) Stock Analysis: Unlocking an 11% Upside with Robust Revenue Growth

Incyte Corporation (NASDAQ: INCY) stands tall in the biotechnology industry, a sector known for its innovation and rapid growth. With a market capitalization of $19.41 billion, Incyte is a notable..

Danaher Corporation (DHR) Investor Outlook: Evaluating a 44% Potential Upside

For investors eyeing opportunities in the healthcare sector, Danaher Corporation (NYSE: DHR) presents a noteworthy consideration. With a market capitalization of approximately $121.74 billion, Danaher is strategically positioned in the..

Mettler-Toledo International, Inc. (MTD) Stock Analysis: A Precision Instrument Powerhouse with 20% Upside Potential

Mettler-Toledo International, Inc. (NYSE: MTD) is a prominent player in the diagnostics and research industry, offering a wide array of precision instruments and services. Headquartered in Greifensee, Switzerland, the company..

IDEXX Laboratories, Inc. (IDXX) Investor Outlook: Unveiling a 26.78% Potential Upside in the Diagnostics Arena

Investors with an eye on the healthcare sector should consider IDEXX Laboratories, Inc. (NASDAQ: IDXX), a prominent player in the diagnostics and research industry with a particular focus on animal..

AstraZeneca PLC (AZN) Stock Analysis: Strong Buy Ratings and a 20% Upside Potential

AstraZeneca PLC (NASDAQ: AZN), a prominent player in the healthcare sector, stands as a titan among global drug manufacturers. With a market capitalization of $290.06 billion, this UK-based biopharmaceutical company..

Medtronic plc (MDT) Stock Analysis: Exploring a 36% Potential Upside for Investors

Medtronic plc (NYSE: MDT), a titan in the medical devices industry, is capturing investor attention with a substantial potential upside of 36.23%. This renowned company, headquartered in Galway, Ireland, operates..

CVS Health Corporation (CVS) Stock Analysis: A Healthcare Giant with a 9.25% Potential Upside

CVS Health Corporation (NYSE: CVS), a titan in the healthcare sector, offers a fascinating investment opportunity, especially for those interested in healthcare plans and services. With a market capitalization of..

Cardinal Health, Inc. (CAH) Stock Analysis: Unveiling a 22% Upside Potential in the Healthcare Sector

Cardinal Health, Inc. (NYSE: CAH), a prominent player in the healthcare sector, is capturing investor attention with a potential upside of 22.22%. With a robust market capitalization of $47 billion,..

Waters Corporation (WAT) Stock Analysis: Analyst Ratings Signal 16.99% Upside Potential

Waters Corporation (NYSE: WAT), a notable player in the healthcare sector, is making waves in the diagnostics and research industry. With a market capitalization of $33.62 billion, this U.S.-based company..

Humana Inc. (HUM) Stock Analysis: Navigating Healthcare Growth with Caution Amidst Valuation Concerns

Humana Inc. (NYSE: HUM), a leading player in the healthcare plans sector, represents a significant entity in the United States healthcare market. With a market capitalization of approximately $36.97 billion,..

STERIS plc (STE) Stock Analysis: Unveiling a Promising 18.60% Upside Potential

Investors with an eye on the healthcare sector have much to consider with STERIS plc (NYSE: STE), a prominent player in the medical devices industry. As a company specializing in..

DexCom, Inc. (DXCM) Stock Analysis: Strong Buy Ratings Signal Potential Upside

DexCom, Inc. (NASDAQ: DXCM), a leader in the healthcare sector with a focus on medical devices, has been making significant strides in the continuous glucose monitoring (CGM) market. Headquartered in..

IQVIA Holdings, Inc. (IQV): Analyst Consensus Reveals 36% Upside Potential for Healthcare Giant

Investors with an eye on the healthcare sector should consider the promising outlook for IQVIA Holdings, Inc. (NYSE: IQV), a leader in the diagnostics and research industry. With a substantial..

Intuitive Surgical, Inc. (ISRG) Stock Analysis: A 30.72% Upside Potential Beckons Healthcare Investors

Intuitive Surgical, Inc. (NASDAQ: ISRG) has long been a trailblazer in the healthcare sector, especially within the niche of minimally invasive surgical systems. With its flagship da Vinci Surgical System,..

Boston Scientific Corporation (BSX) Stock Analysis: 44% Potential Upside Signals Promising Investment Opportunity

For investors eyeing opportunities in the healthcare sector, Boston Scientific Corporation (NYSE: BSX) stands out with its robust market presence and promising potential upside. With a market capitalization of $85.88..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds